Drugstars ApS
Credit rating
Company information
About Drugstars ApS
Drugstars ApS (CVR number: 36893974) is a company from KØBENHAVN. The company reported a net sales of 1.6 mDKK in 2020, demonstrating a growth of 53.9 % compared to the previous year. The operating profit percentage was poor at -463 % (EBIT: -7.6 mDKK), while net earnings were -6950.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -103.7 %, which can be considered poor and Return on Equity (ROE) was -117.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -6.4 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Drugstars ApS's liquidity measured by quick ratio was 1.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2016 | 2017 | 2018 | 2019 | 2020 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 1 061.29 | 1 633.57 | |||
Gross profit | - 963.10 | -1 939.62 | -4 396.56 | -2 068.71 | |
EBIT | -1 191.21 | -3 743.96 | -9 086.42 | -7 563.63 | |
Net earnings | - 944.01 | -3 302.45 | -8 330.14 | -6 950.40 | |
Shareholders equity total | 1 281.68 | 2 874.63 | 6 591.44 | - 358.96 | |
Balance sheet total (assets) | 1 489.92 | 3 202.52 | 8 979.63 | 5 246.41 | |
Net debt | -1 082.09 | -2 452.29 | -7 486.89 | - 724.84 | |
Profitability | |||||
EBIT-% | -856.2 % | -463.0 % | |||
ROA | -79.9 % | -159.6 % | -101.2 % | -103.7 % | |
ROE | -73.7 % | -158.9 % | -126.4 % | -117.4 % | |
ROI | -91.9 % | -178.8 % | -137.8 % | -166.8 % | |
Economic value added (EVA) | - 943.94 | -3 310.20 | -20.45 | -8 260.48 | -6 755.74 |
Solvency | |||||
Equity ratio | 86.0 % | 89.8 % | 73.4 % | -6.4 % | |
Gearing | 1.2 % | 0.5 % | -690.6 % | ||
Relative net indebtedness % | -480.4 % | 147.0 % | |||
Liquidity | |||||
Quick ratio | 7.6 | 10.1 | 3.7 | 1.7 | |
Current ratio | 7.6 | 10.1 | 3.7 | 1.7 | |
Cash and cash equivalents | 1 097.13 | 2 467.74 | 7 486.89 | 3 203.76 | |
Capital use efficiency | |||||
Trade debtors turnover (days) | 171.5 | 233.3 | |||
Net working capital % | 611.6 % | 125.4 % | |||
Credit risk | |||||
Credit rating | B | B | B | B |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.